Feb 02, 2026
4:25
For every 25 shares held, investors received 4. The price per share adjusted from $0.64 to $4.00.
The split itself did not change the total investment value.
Psyence Biomedical Ltd. (NASDAQ:PBM) operates in the Pharmaceuticals: major industry.
Psyence Biomedical Ltd. company overviewPsyence Biomedical Ltd.'s most recent stock split was on February 2, 2026. It was a 4-for-25 reverse split, so shareholders received 4 shares for every 25 they held.
Psyence Biomedical Ltd. (NASDAQ:PBM) has split its stock 3 times: a 1-for-75 reverse split on November 26, 2024, a 100-for-797 reverse split on May 5, 2025, and a 4-for-25 reverse split on February 2, 2026.
Psyence Biomedical Ltd. has split its stock 3 times. This history records 3 reverse splits between November 26, 2024 and February 2, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Psyence Biomedical Ltd.'s 4-for-25 reverse split on February 2, 2026, every 25 shares became 4 shares. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Psyence Biomedical Ltd. has not announced a new split in our records. Its most recent split was on February 2, 2026, less than a year ago. Companies announce splits in advance, and any new NASDAQ:PBM split will appear on this page.
Already premium?